Professor Gordon Dougan is a world authority on vaccines, genomics and the epidemiology of infectious diseases including antibiotic resistance. He has contributed to the development of several vaccines (e.g. whooping cough, cholera, typhoid) and was previously voted in the top ten most influential people in the vaccine world. He has served on numerous international bodies and organisations including, member of the UK Governments Commission on Human Medicines (MHRA) COVID-19 Vaccines Benefit Risk Expert Working Group, World Health Organization, the GSK Institute for Global Health, the International Vaccine Institute (Korea) and Wellcome. He is currently a Professor in the Department of Medicine, University of Cambridge and was formerly Head of Pathogen Research at the Wellcome Sanger Institute. He has worked in the Pharmaceutical industry developing vaccine for over a decade.
Professor Gordon Dougan's Lab study the pathogenesis, epidemiology and vaccinology/immunology of infections. We specialise in using genomics to rapidly identify infection signatures in laboratory and clinical samples and investigate how medicines work on pathogens. Our mechanistic focus is on enteric bacterial disease but with an emphasis on invasive salmonella infections such as typhoid.
We exploit a combination of genetics, genomics and laboratory technologies (imaging, FACS, microbiology). We work with Cambridge University Hospitals to develop rapid methods for identifying and defining antibiotic resistant infections in patients. Our aim is to influence clinical practice to improve care.
The Dougan Lab works with partners to have similar impact internationally. We work strategically with The International Vaccine Institute in Korea, Hong Kong University and collaborators and sites in many countries.
We work in both the basic and applied sciences and have an interest in career development.
We operate in state-of-the-art laboratories based in the Jeffrey Cheah Biomedical Centre in Cambridge including CL3 facilities and have access to most high end equipment for conducting modern molecular research. We work in the data sciences, in the laboratory and in the field
We are based at the Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) which is part of the Department of Medicine, University of Cambridge. Our laboratories and offices are located in the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus.